The global body slimming devices market was estimated to be worth US$ 3,911.9 million in 2023 by Future Market Insights (FMI). A CAGR of about 3.8% is projected for the duration of the forecast period. It is anticipated that the market will be worth US$5,674.4 million by 2034.
With no negative effects on the body’s other tissues, slimming devices help eliminate unwanted fat that has been deposited in the body. As they dissolve and burn fat, these devices guarantee to aid in weight loss and fat reduction without the need for a workout regimen. Also, they help to tighten the skin and increase its suppleness, which results in skin tone.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-18304
One of the key factors propelling the development of the market is the increasing obesity incidence among people worldwide. The rise in chronic illnesses, including hypertension, diabetes, and orthopedic conditions brought on by sedentary and unhealthy lifestyles, is driving the expansion of the slimming device industry.
The growing awareness of health issues and the benefits of digitization, which makes it simpler to obtain information about the consequences of being overweight, also have an impact on the slimming device market. Positive factors influencing the market for slimming devices include rising awareness of appealing appearance, changing lifestyles, a growing desire to look better, and the expansion of the online retail industry. During the projection period, slimming device market participants will have lucrative prospects owing to product developments and technical improvements.
Growing disposable income in emerging countries, sedentary lifestyles, and increased government attempts to raise awareness among obese populations are expected to significantly drive market growth.
Key Takeaways:
- The market value share for body slimming devices was around 24.1% in 2022.
- Sales of body slimming devices expanded at a CAGR of 2.5% from 2019 to 2023.
- India held a significant market share of about 27.8% in South Asia in 2022.
- Germany held around 4.6% share of the global market in 2022 and is expected to rise steadily in the forecast period.
- Body slimming device demand in China is anticipated to rise at a steady CAGR of 4.8% during the forecast period.
“Rising prevalence of gynecomastia and the increasing adoption of minimally invasive and more effective procedures for gynecomastia are set to propel the sales of body slimming devices across the globe,” opines Sabyasachi Ghosh, Associate Vice President at Future Market Insights (FMI).
Competitive Landscape:
Leading players are adopting key strategies such as product launches, partnerships, and agreements to strengthen their market presence as well as to expand their existing product portfolios. Several leading companies are innovating new technologies that are minimally invasive and are used to reduce patients’ time in hospitals, lower the chances of infection, and save costs.
For instance,
- In January 2023, Fotona launched Fotona4D. It is a cutting-edge laser procedure that targets four distinct dimensions of the skin to rejuvenate and tighten from the inside out.
- In April 2019, a dermal filler named Juvéderm VOLUX was produced by ALLERGAN to improve the chin and jawline.
Key Players:
- Alma Lasers
- Allergan Plc
- MerzPharmaGmbh
- Candela Medical Ltd.
- Solta Medical Bausch Health Companies, Inc.
- Lutronic Corporation
- InMode Ltd.
- Fotona
- Sofwave Medical Ltd.
- Sciton Inc.
- Lumenis
- Cynosure, Inc. (Hologic, Inc)
- Bausch Health Companies Inc
- Cutera
- Invasix Aesthetic Solutions
- Venus Concept
- Zeltiiq
- Erchonia Medical
Key Segments:
By Product:
- Cryolipolysis
- Diode Laser
- High-intensity Focused Electromagnetic Field (HIFEM)
- Radiofrequency (RF)
- High-intensity Focused Ultrasound (HIFU)
By End-user:
- Hospital Setting
- Ambulatory Surgical Centers
- Plastic Surgery and Cosmetic Clinics
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- The Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
